These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20682511)

  • 21. Beta blockers for patients with lung disease?
    Harv Heart Lett; 2001 Nov; 12(3):2-3. PubMed ID: 11724686
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD?
    Baselli LM; Oswald MA; Nashelsky JM
    J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911
    [No Abstract]   [Full Text] [Related]  

  • 24. [The place of β-adrenoblockers in the treatment of cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Statsenko ME; Derevianchenko MV
    Kardiologiia; 2012; 52(12):57-63. PubMed ID: 23237442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of beta-blockers as a cornerstone of cardiovascular therapy.
    Hollenberg NK
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
    Au DH; Bryson CL; Fan VS; Udris EM; Curtis JR; McDonell MB; Fihn SD
    Am J Med; 2004 Dec; 117(12):925-31. PubMed ID: 15629731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
    Minor DS; Meyer AM; Long RC; Butler KR
    J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.
    Ormiston TM; Salpeter SR
    Heart Fail Monit; 2003; 4(2):45-54. PubMed ID: 14724718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
    Curkendall SM; DeLuise C; Jones JK; Lanes S; Stang MR; Goehring E; She D
    Ann Epidemiol; 2006 Jan; 16(1):63-70. PubMed ID: 16039877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selection criteria for differential therapy with beta receptor blockers].
    Knauf H; Mutschler E; Palm D
    Dtsch Med Wochenschr; 1990 Dec; 115(51-52):1963-70. PubMed ID: 1979770
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.
    Bhatt SP; Vegas-Sánchez-Ferrero G; Rahaghi FN; MacLean ES; Gonzalez-Serrano G; Come CE; Kinney GL; Hokanson JE; Budoff MJ; Cuttica MJ; Wells JM; Estépar RSJ; Washko GR
    Am J Respir Crit Care Med; 2017 Dec; 196(11):1484-1488. PubMed ID: 28441027
    [No Abstract]   [Full Text] [Related]  

  • 34. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
    Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A
    J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of beta-blockers in patients with COPD: current perspective.
    Malerba M; Montuschi P; Radaeli A; Pirisi M
    Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.
    Andrus MR; Loyed JV
    Drugs Aging; 2008; 25(2):131-44. PubMed ID: 18257600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bronchial obstruction exacerbated during beta blocker therapy].
    Nagy LB; Varjas J; Bátori M
    Orv Hetil; 1989 Oct; 130(44):2365-8. PubMed ID: 2573028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł; Duława A; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with beta blockers in people with COPD.
    Kazani S; Israel E
    BMJ; 2011 May; 342():d2655. PubMed ID: 21558358
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.